STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,123 | -63.9% | 47,747 | -2.7% | 0.00% | -50.0% |
| Q2 2023 | $521,689 | +60.4% | 49,077 | +25.7% | 0.00% | +100.0% |
| Q1 2023 | $325,328 | -12.8% | 39,055 | -3.4% | 0.00% | -50.0% |
| Q4 2022 | $373,012 | +3.0% | 40,413 | +43.2% | 0.00% | 0.0% |
| Q3 2022 | $362,000 | -2.9% | 28,223 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $373,000 | -22.9% | 28,223 | +22.6% | 0.00% | 0.0% |
| Q1 2022 | $484,000 | +8.5% | 23,013 | +23.7% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | -12.7% | 18,603 | -7.4% | 0.00% | 0.0% |
| Q3 2021 | $511,000 | -11.3% | 20,087 | +17.4% | 0.00% | -33.3% |
| Q2 2021 | $576,000 | – | 17,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |